Literature DB >> 5239039

Direct measurement of the rates of synthesis of plasma proteins in control subjects and patients with gastrointestinal protein loss.

R D Wochner, S M Weissman, T A Waldmann, D Houston, N I Berlin.   

Abstract

The guanido carbon of hepatic arginine is the common precursor of urea and of the arginine of plasma proteins synthesized in the liver. It is possible to measure the momentary synthetic rates of plasma proteins by "pulse labeling" this arginine pool with bicarbonate-(14)C. In the current study, this method has been adapted in order to use urinary urea data and was applied to control subjects and patients with gastrointestinal protein loss. The assumptions required for this determination are discussed. There was close agreement between albumin synthetic rates measured by this method and albumin catabolic rates derived from simultaneous albumin-(131)I studies, supporting the validity of the method and suggesting that there is relatively little fluctuation in the rate of albumin synthesis from time to time. The albumin synthetic rates in six control subjects averaged 5.8 mg/kg per hr, while those of five patients with gastrointestinal protein loss averaged 7.2 mg/kg per hr. Thus in these patients, there was relatively little acceleration of albumin synthesis in response to continued loss of plasma proteins into the gastrointestinal tract. Fibrinogen synthetic rates averaged 1.9 mg/kg per hr in five control subjects and 3.2 mg/kg per hr in five patients with gastrointestinal protein loss. Transferrin synthetic rates exhibited considerable individual variation in both groups and averaged 0.24 mg/kg per hr in four control subjects and 0.31 mg/kg per hr in five patients with gastrointestinal protein loss. The method employed in this study offers several advantages in studying plasma protein metabolism. It provides a direct measurement of protein synthesis, applicable to several proteins simultaneously, does not require a long-term steady state in the metabolism of the proteins, and is capable of measuring short-term fluctuations in synthetic rates. Therefore, this approach is applicable to the investigation of the physiological factors controlling the rates of synthesis for plasma proteins.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5239039      PMCID: PMC297250          DOI: 10.1172/JCI105812

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  34 in total

1.  MEASUREMENT OF SYNTHESIS RATES OF LIVER-PRODUCED PLASMA PROTEINS.

Authors:  A S MCFARLANE
Journal:  Biochem J       Date:  1963-11       Impact factor: 3.857

2.  Studies of the metabolism and distribution of albumin with autologous I131-albumin in healthy men.

Authors:  Y TAKEDA; E B REEVE
Journal:  J Lab Clin Med       Date:  1963-02

3.  Use of precursor product relationships in determining serum albumin half-life.

Authors:  S WEISSMAN; D P TSCHUDY; H BACCHUS; M EUBANKS
Journal:  J Lab Clin Med       Date:  1961-01

4.  The role of the gastrointestinal system in "idiopathic hypoproteinemia".

Authors:  T A WALDMANN; J L STEINFELD; T F DUTCHER; J D DAVIDSON; R S GORDON
Journal:  Gastroenterology       Date:  1961-09       Impact factor: 22.682

5.  A practical method for plasma albumin turnover studies.

Authors:  J D PEARSON; N VEALL; H VETTER
Journal:  Strahlentherapie       Date:  1958

6.  Iron and protein kinetics studied by means of doubly labeled human crystalline transferrin.

Authors:  J H KATZ
Journal:  J Clin Invest       Date:  1961-12       Impact factor: 14.808

7.  Measurement of protein turnover in rat liver.

Authors:  R W SWICK
Journal:  J Biol Chem       Date:  1958-04       Impact factor: 5.157

8.  The theory of tracer experiments with 131I-labelled plasma proteins.

Authors:  C M MATTHEWS
Journal:  Phys Med Biol       Date:  1957-07       Impact factor: 3.609

9.  SERUM ALBUMIN TURNOVER IN NORMAL SUBJECTS AND PATIENTS WITH CIRRHOSIS MEASURED BY 131I-LABELLED HUMAN ALBUMIN.

Authors:  P WILKINSON; C L MENDENHALL
Journal:  Clin Sci       Date:  1963-10       Impact factor: 6.124

10.  Plasma protein synthesis in the liver: method for measurement of albumin formation in vivo.

Authors:  E B REEVE; J R PEARSON; D C MARTZ
Journal:  Science       Date:  1963-03-08       Impact factor: 47.728

View more
  15 in total

1.  Familial hypercatabolic hypoproteinemia. A disorder of endogenous catabolism of albumin and immunoglobulin.

Authors:  T A Waldmann; W D Terry
Journal:  J Clin Invest       Date:  1990-12       Impact factor: 14.808

2.  [The regulation of serum albumin in physiological and pathological conditions (author's transl)].

Authors:  K Weigand
Journal:  Klin Wochenschr       Date:  1977-04-01

Review 3.  The synthesis and degradation of liver-produced proteins.

Authors:  A S Tavill
Journal:  Gut       Date:  1972-03       Impact factor: 23.059

4.  A plasma protein fractionation procedure for use in studies of protein metabolism.

Authors:  J Ho; K N Jeejeebhoy; R H Painter
Journal:  Biochem J       Date:  1974-09       Impact factor: 3.857

5.  The nephrotic syndrome.

Authors:  A S Relman
Journal:  Calif Med       Date:  1971-12

Review 6.  Serum albumin.

Authors:  M A Rothschild; M Oratz; S S Schreiber
Journal:  Am J Dig Dis       Date:  1969-10

7.  Hepatic albumin and urea synthesis: The mathematical modelling of the dynamics of [14C]carbonate-derived guanidine-labelled arginine in the isolated perfused rat liver.

Authors:  A S Tavill; D Nadkarni; J Metcalfe; E Black; R Hoffenberg; E R Carson
Journal:  Biochem J       Date:  1975-09       Impact factor: 3.857

Review 8.  Clinical practice. Protein-losing enteropathy in children.

Authors:  Marjet J A M Braamskamp; Koert M Dolman; Merit M Tabbers
Journal:  Eur J Pediatr       Date:  2010-06-23       Impact factor: 3.183

9.  Albumin synthesis in cirrhotic subjects with ascites studied with carbonate-14C.

Authors:  M A Rothschild; M Oratz; D Zimmon; S S Schreiber; I Weiner; A Van Caneghem
Journal:  J Clin Invest       Date:  1969-02       Impact factor: 14.808

10.  Hypercatabolism of normal IgG; an unexplained immunoglobulin abnormality in the connective tissue diseases.

Authors:  R D Wochner
Journal:  J Clin Invest       Date:  1970-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.